Replies to post #301186 on Anavex Life Sciences Corp (AVXL)

[RedShoulder]

The most likely is an Autism Spectrum Disorder and more specifically fragile X-associated tremor ataxia syndrome (FXTAS).

I agree with that, Dr Randi Haggerman is all over FXTAS.

[falconer66a]

Autism applications would be awesome.

The most likely is an Autism Spectrum Disorder...

If an Anavex molecule proves to be either prophylactic or therapeutic for autism, consider the numbers.

About 1 in 54 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network.
https://www.cdc.gov/ncbddd/autism/data.html

Almost 2% of kids born today are intellectually and behaviorally hindered by autism. If an Anavex molecule could reduce that by any fraction it would be a major revenue source for the company — and save billions of dollars for both parents and societies. It would be one of the major drug advances since antibiotics and psychotherapeutics.

May it be so.

[RedShoulder]

Dr Hagerman and "Fragile X–Associated Tremor/Ataxia Syndrome | FXTAS"

Fragile X–associated tremor/ataxia syndrome was first described in five grandfathers of children with Fragile X syndrome in 2001 by Dr. Randi Hagerman and her colleagues at the MIND Institute, University of California, Davis. These men were generally healthy until the onset of the FXTAS-related symptoms.

https://fragilex.org/understanding-fragile-x/tremor-ataxia-syndrome-fxtas/